Principles of human chemoprevention

Hematology/Oncology Clinics of North America

Volumn 12, Issue 5, 1998, Pages 935-941

  Meyskens F L , Jr ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CAROTENE; DNA; EFLORNITHINE; RETINOL DERIVATIVE; TUMOR MARKER;

CANCER MORTALITY; CANCER PREVENTION; CARCINOGENESIS; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLON CANCER; DIET; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; IMMUNOMODULATION; LUNG CANCER; MORBIDITY; PRIORITY JOURNAL; REVIEW; TUMOR PROMOTION;

EID: 0031667075     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70034-4     Document Type: Article

References (21)

1. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers N Engl J Med 330 1994 1029 1035
2. J.S. Bertram L.N. Kolonel F.L. Meyskens Jr Rationale and strategies for chemoprevention of cancer in humans Cancer Res 47 1987 3012 3031
3. E.R. Fearon B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759
4. G.E. Goodman The clinical evaluation of cancer chemoprevention agents: Defining and contrasting phase I, II and III objectives Cancer Res 52 1992 2752 2758
5. W.K. Hong S.M. Lippman L.M. Itri Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck (SCCHN) N Engl J Med 323 1990 795 801
6. G.J. Kellogg J.A. Crowell E.T. Hawk Strategy and planning for chemopreventive drug development: Clinical development phase II J Cell Biochem 26 suppl 1996 64 71
7. K.H. Kraemer J.J. DiGiuvanna Moshell Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin N Engl J Med 318 1986 1633 1637
8. Levine NS, Moon TE, Cartmel B, et al: Randomized trial of retinol and 13-cis retinoic acid for patients at high risk for skin cancer recurrence. Cancer Epidemiol Biomarkers Prev, in press
9. S. Lippman J. Kessler F.L. Meyskens Jr Retinoids as preventive and therapeutic anticancer agents Cancer Treat Rep II 1987 493 515 I:71:391–405, 1987
10. R.R. Love P.P. Carbone A.K. Verma Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithine J Natl Cancer Inst 85 1993 732 737
11. F.L. Meyskens Jr Cancer prevention M.C. Brain P.P. Carbone Current Therapy in Hematology-Oncology–3 1988 BC Decker Philadelphia 275 277
12. F.L. Meyskens Jr Biology and intervention of the premalignant process Cancer Bull 43 1992 475 480
13. F.L. Meyskens Jr Biomarkers, intermediate endpoints and cancer prevention. J Natl Cancer Inst Monogr 13 1992 177 182
14. F.L. Meyskens Jr Strategies for prevention of cancer in humans Oncology Supplement 6 2 1992 16 24
15. F.L. Meyskens Jr Principles of cancer prevention C.S. Haskell Cancer Treatment ed 4 1995 WB Saunders Philadelphia 10 13
16. Meyskens FL Jr : Chemoprevention of cancer: A reasonable strategy? Recent Results Cancer Res, in press
17. F.L. Meyskens Jr S.S. Emerson D. Pelot Dose de-escalation chemoprevention trial of difluoromethylornithine in patients with colon polyps J Natl Cancer Inst 86 1994 1122 1130
18. Meyskens FL Jr, Gerner EW, Emerson S, et al: A randomized double-blind placebo-controlled phase IIb trial of difluoromethylornithine for colon cancer prevention. J Natl Cancer Inst, in press
19. F.L. Meyskens Jr E.S. Surwit T.E. Moon Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans retinoic acid: A randomized trial J Natl Cancer Inst 86 1994 539 543
20. G.S. Omenn G.E. Goodman M.D. Thronquist Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease N Engl J Med 3334 1996 1150 1155
21. W. Zhou L.J. Sokoll D.J. Bruzek Identifying markers for pancreatic cancer by gene expression analysis Cancer Epidemiol Biomarkers Prev 7 1998 109 112